न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - tadalafil 10mg;   - film coated tablet - 10 mg - active: tadalafil 10mg   excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 32k12884 purified talc sodium laurilsulfate - erectile dysfunction (ed) in adult men. in order for cialis to be effective in treating ed, sexual stimulation is required. · moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult men · adult men with co-existing ed and luts associated with bph

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - tadalafil 2.5mg;   - film coated tablet - 2.5 mg - active: tadalafil 2.5mg   excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow y-30-12863-a purified talc sodium laurilsulfate - the treatment of erectile dysfunction. in order for cialis to be effective, sexual stimulation is required.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - tadalafil 20mg;   - film coated tablet - 20 mg - active: tadalafil 20mg   excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 32k12884 purified talc sodium laurilsulfate - erectile dysfunction (ed) in adult men. in order for cialis to be effective in treating ed, sexual stimulation is required. · moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult men · adult men with co-existing ed and luts associated with bph

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

physicians total care, inc. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil 5 mg - cialis® is indicated for the treatment of erectile dysfunction (ed). cialis is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). cialis is indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). administration of cialis to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, cialis was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . cialis is contraindicated in patients with a known serious hypersensitivity to tadalafil (cialis or adcirca® ). hypersensitivity reactions have been reported, including stevens-johnson syndrome and exfoliative dermatitis [see adverse reactions (6.2)] . pregnancy category b — cialis (tadalafil) is not indicated for use in women. there are no adequate and well controlled studies of cialis use in pregnant women. animal reproduction studies in rats and mice revealed no evidence of fet

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

stat rx usa llc - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil 10 mg - cialis is indicated for the treatment of erectile dysfunction. administration of cialis to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, cialis was shown to potentiate the hypotensive effect of nitrates. this is thought to result from the combined effects of nitrates and cialis on the nitric oxide/cgmp pathway [see clinical pharmacology (12.2)] . cialis is contraindicated in patients with a known serious hypersensitivity to tadalafil (cialis or adcircatm ). hypersensitivity reactions have been reported, including stevens-johnson syndrome and exfoliative dermatitis [see adverse reactions (6.2)] . pregnancy category b — cialis (tadalafil) is not indicated for use in women. there are no adequate and well controlled studies of cialis use in pregnant women. animal reproduction studies in rats and mice revealed no evidence of fetal harm. non-teratogenic effects — animal reproduction studies showed no evidence of te

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil 20 mg - cialis ® is indicated for the treatment of erectile dysfunction (ed). cialis is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). cialis is indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if cialis is used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of cialis decreases from 4 weeks until 26 weeks, and the incremental benefit of cialis beyond 26 weeks is unknown [see clinical studies ( 14.3)] . administration of cialis to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, cialis was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology ( 12.2)] . cialis is contraindicated in patients with a known serious hypersensitivity to tadalafil (ci

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

rebel distributors corp. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil 10 mg - cialis is indicated for the treatment of erectile dysfunction. administration of cialis to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, cialis was shown to potentiate the hypotensive effect of nitrates. this is thought to result from the combined effects of nitrates and cialis on the nitric oxide/cgmp pathway [see clinical pharmacology (12.2)] . is contraindicated in patients with a known serious hypersensitivity to tadalafil (cialis or adcirca). hypersensitivity reactions have been reported, including stevens-johnson syndrome and exfoliative dermatitis [see adverse reactions (6.2)] . pregnancy category b — cialis (tadalafil) is not indicated for use in women. there are no adequate and well controlled studies of cialis use in pregnant women. animal reproduction studies in rats and mice revealed no evidence of fetal harm. non-teratogenic effects — animal reproduction studies showed no evidence of teratogenici

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

eli lilly and company - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil 2.5 mg - cialis® is indicated for the treatment of erectile dysfunction (ed). cialis is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). cialis is indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if cialis is used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of cialis decreases from 4 weeks until 26 weeks, and the incremental benefit of cialis beyond 26 weeks is unknown [see clinical studies (14.3)] . administration of cialis to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, cialis was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . cialis is contraindicated in patients with a known serious hypersensitivity to tadalafil (cialis or adcirca® ). hypersensitivity reactions have been reported, including stevens-johnson syndrome and exfol

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil 5 mg - cialis® is indicated for the treatment of erectile dysfunction (ed). cialis is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). cialis is indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if cialis is used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of cialis decreases from 4 weeks until 26 weeks, and the incremental benefit of cialis beyond 26 weeks is unknown [see clinical studies (14.3)] . administration of cialis to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, cialis was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . cialis is contraindicated in patients with a known serious hypersensitivity to tadalafil (cialis or adcirca® ). hypersensitivity reactions have been reported, including stevens-johnson syndrome and exfol

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

cardinal health - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil 5 mg - cialis® is indicated for the treatment of erectile dysfunction (ed). if cialis is used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of cialis decreases from 4 weeks until 26 weeks, and the incremental benefit of cialis beyond 26 weeks is unknown [see clinical studies (14.3)] . administration of cialis to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, cialis was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . cialis is contraindicated in patients with a known serious hypersensitivity to tadalafil (cialis or adcirca® ). hypersensitivity reactions have been reported, including stevens-johnson syndrome and exfoliative dermatitis [see adverse reactions (6.2)] . do not use cialis in patients who are using a gc stimulator, such as riociguat. pde5 inhibitors, including cialis, may potentiate the hypoten